No Pfizer Coronavirus Vaccine Before Election
October 16, 2020 – Pfizer will not seek emergency clearance for its coronavirus vaccine until the third week of November, the company’s chief executive said in a statement on the Pfizer website Friday.
Reversing the company’s previous claims that it would seek approval in October is a blow to U.S. President Donald Trump, who has repeatedly said a vaccine will be available before election day on November 3. The New York Times reported.
Even though Pfizer might have preliminary data on the vaccine’s effectiveness by the end of October, collecting the safety and manufacturing data would take at least until the third week of November, Dr Albert Bourla said in the press release.
Pfizer’s announcement was well received by some scientists.
“It’s good, really good,” said Dr. Eric Topol, clinical trials expert at Scripps Research in San Diego. Time. He was one of 60 public health officials and other medical experts who sent a letter to Pfizer urging him not to rush his vaccine, Time reported.
Pfizer is one of four companies to offer a vaccine against the coronavirus in advanced clinical trials in the United States. The others are Moderna, AstraZeneca and Johnson & Johnson. Pfizer gave the most optimistic timeline, while the other three said later this year it was more likely.
Our sincere thanks to